International clinical trial tests targeted drug for melanoma
Links shared publicly online about this topic.
- 688total visits
International clinical trial tests targeted drug for melanoma
View full resource at physorg.com
Tags: Skin, Cancer, Skin Cancer, Melanoma, Drug, Clinical Trial
Most Recently Shared on November 30, 2010 at 9:51 pm By:
International clinical trial tests targeted drug for melanoma http://bit.ly/i4zj99
Find Targeted Therapies for Melanoma
therapy.collabrx.com — “Apply the latest advances in molecular oncology to find personalized tests and treatments for advanced melanoma. Find the most relevant and promising clinical trials in cancer -- targeted therapies such as PLX4032, GSK2118436, Gleevec and Ipilimumab.” View full resource at therapy.collabrx.com
Most Recently Shared on March 1, 2011 at 4:22 pm By:
Plexxikon, Genentech enter PLX4032 co-promotion agreement
news-medical.net — “Plexxikon, Inc., announced today that it has signed an agreement with Genentech to co-promote PLX4032 (RG7204) in the United States. PLX4032, an oral, novel kinase inhibitor that targets the oncogenic BRAF mutation, is being tested in late-stage clinical trials for the treatment of metastatic melanoma.” View full resource at news-medical.net
Most Recently Shared on January 7, 2011 at 12:28 pm By:
Plexxikon, Genentech enter PLX4032 co-promotion agreement: Plexxikon, Inc., announced today that it has signed a... http://bit.ly/hq3IEr
Targeted Therapy for Melanoma
rush.edu — “Rush University Medical Center is participating in an international clinical trial testing a novel drug to treat certain kinds of melanoma, a deadly skin cancer.” View full resource at rush.edu
Most Recently Shared on December 20, 2010 at 2:44 pm By:
Rush enrolls first U.S. patient in international clinical trial for new melanoma drug http://budurl.com/mv2h
International Clinical Trial Tests Targeted Drug For Melanoma
medicalnewstoday.com — “Rush University Medical Center has just enrolled the first U.S. patient in an international clinical trial testing a novel drug to treat certain kinds of melanoma, a deadly skin cancer that in its” View full resource at medicalnewstoday.com
Most Recently Shared on December 1, 2010 at 5:05 pm By:
MNT Clinical Trials Health News
International Clinical Trial Tests Targeted Drug For Melanoma http://mnt.to/3Nmx #clinicaltrials
Target Cancer - New Drugs Stir Debate on Rules of Clinical Trials - NYTimes.com
nytimes.com — “Two cousins developed the same lethal cancer; only one could take part in an experimental drug trial. Critics say that new science behind the drugs has eclipsed the old rules, and ethics, of testing them.” View full resource at nytimes.com
Most Recently Shared on September 22, 2010 at 10:46 am By:
annabel bentley Physician, Doctor, and Surgeon
Hype or hope: NYT story re PLX4032 for malignant melanoma... ethics of RCTs & journalism? http://nyti.ms/c6biSg
Target Cancer - New Drugs Stir Debate on Rules of Clinical Trials - NYTimes.com
nytimes.com — “Two cousins developed the same lethal cancer; only one could take part in an experimental drug trial. Critics say that new science behind the drugs has eclipsed the old rules, and ethics, of testing them.” View full resource at nytimes.com
Most Recently Shared on September 21, 2010 at 9:50 pm By:
Dr. Susan Beck CAM, Nutritionist, PhD, Acupuncturist, and Doctor
Heartbreaking story in the NYTimes from Sat. 2 cousins w/ melanoma, 2 different treatments leading to 2 different chances http://ow.ly/2HLCJ
Experimental targeted cancer drug helps four out of five metastatic melanoma patients - latimes.com
latimes.com — “An experimental anticancer drug that targets a specific genetic mutation benefits 80% of patients with metastatic melanoma, although in some cases the benefit was short-lived, researchers said Wednesday. The results came in a relatively small Phase II clinical trial, and testing will now proceed to a larger Phase III trial to gain approval for marketing the drug, called PLX4032. Researchers hope the drug might also provide benefits for some other types of tumors that share the same genetic defec” View full resource at latimes.com
Most Recently Shared on August 27, 2010 at 3:39 am By:
elaine schattner Oncologist, Hematologist, Physician, Doctor, and Internist
New drug targeting BRAF shows activity in melanoma (preliminary; science behind this interesting, promising?) LATimes - http://bit.ly/cGfsSe
Experimental targeted cancer drug helps four out of five metastatic melanoma patients - latimes.com
latimes.com — “An experimental anticancer drug that targets a specific genetic mutation benefits 80% of patients with metastatic melanoma, although in some cases the benefit was short-lived, researchers said Wednesday. The results came in a relatively small Phase II clinical trial, and testing will now proceed to a larger Phase III trial to gain approval for marketing the drug, called PLX4032. Researchers hope the drug might also provide benefits for some other types of tumors that share the same genetic defec” View full resource at latimes.com
Most Recently Shared on August 27, 2010 at 1:13 am By:
Experimental targeted cancer drug helps 4 out of 5 metastatic melanoma patients http://bit.ly/9oDJtY
Advertisement
